Literature DB >> 18563297

Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy.

Pedram Tabatabaei1, Per Bergström, Roger Henriksson, A Tommy Bergenheim.   

Abstract

OBJECTIVE: The metabolism of malignant glioma was studied in 13 patients. The main objective was to perform a study of the metabolic pattern of glucose, lactate, pyruvate, glutamate and glycerol in tumour tissue during base-line conditions and to detect any changes in the metabolism during radiotherapy.
METHOD: During a stereotactic biopsy, two microdialysis catheters were implanted: one in tumour and one in peri-tumoural tissue. Fasting samples were analysed daily, before and during 5 days of radiotherapy given with 2 Gy fractions.
RESULTS: Base-line levels of glucose and pyruvate were significantly lower in tumour compared to peri-tumoural tissue (P = 0.04 and 0.023, respectively). The lactate/pyruvate ratio was significantly higher in tumour tissue (P = 0.022). In general, the levels of lactate, glutamate and glycerol were higher in tumour tissue, although not statistically significant. Further, we could not detect any significant changes during the 5 days of radiotherapy in any of the metabolites analysed.
CONCLUSION: Radiotherapy up to 10 Gy given in five fractions does not influence the glucose metabolism nor does it induce any acute cytotoxic effect detected with glutamate or glycerol in malignant glioma, as assessed by microdialysis. The study confirms the glycolytic properties of glucose metabolism in malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563297     DOI: 10.1007/s11060-008-9625-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

Review 1.  Metabolism of the malignant astrocytoma.

Authors:  J R Mangiardi; P Yodice
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

2.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

3.  Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells.

Authors:  A Klegeris; D G Walker; P L McGeer
Journal:  J Neuroimmunol       Date:  1997-09       Impact factor: 3.478

4.  Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis.

Authors:  Michael Roslin; Roger Henriksson; Per Bergström; Urban Ungerstedt; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

5.  Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain.

Authors:  L Hillered; J Valtysson; P Enblad; L Persson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

6.  Applications of MRS in the evaluation of focal malignant brain lesions.

Authors:  S Delorme; M-A Weber
Journal:  Cancer Imaging       Date:  2006-06-22       Impact factor: 3.909

7.  Respiratory patterns in human brain tumors.

Authors:  T Lichtor; G J Dohrmann
Journal:  Neurosurgery       Date:  1986-12       Impact factor: 4.654

8.  Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.

Authors:  A Tommy Bergenheim; Jacek Capala; Michael Roslin; Roger Henriksson
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

9.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.

Authors:  C G Rhodes; R J Wise; J M Gibbs; R S Frackowiak; J Hatazawa; A J Palmer; D G Thomas; T Jones
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

10.  Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes.

Authors:  Y Cho; S Bannai
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

View more
  17 in total

1.  Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cells.

Authors:  Shivani Ponnala; Chandramu Chetty; Krishna Kumar Veeravalli; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Int J Oncol       Date:  2011-11-07       Impact factor: 5.650

Review 2.  Interrogating Metabolism in Brain Cancer.

Authors:  Travis C Salzillo; Jingzhe Hu; Linda Nguyen; Nicholas Whiting; Jaehyuk Lee; Joseph Weygand; Prasanta Dutta; Shivanand Pudakalakatti; Niki Zacharias Millward; Seth T Gammon; Frederick F Lang; Amy B Heimberger; Pratip K Bhattacharya
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-11       Impact factor: 2.266

3.  Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma.

Authors:  Saadallah Ramadan; Ovidiu C Andronesi; Peter Stanwell; Alexander P Lin; A Gregory Sorensen; Carolyn E Mountford
Journal:  Radiology       Date:  2011-02-25       Impact factor: 11.105

4.  Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.

Authors:  Vera Miranda-Gonçalves; Mrinalini Honavar; Céline Pinheiro; Olga Martinho; Manuel M Pires; Célia Pinheiro; Michelle Cordeiro; Gil Bebiano; Paulo Costa; Isabel Palmeirim; Rui M Reis; Fátima Baltazar
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

5.  Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.

Authors:  Christina Wanka; Joachim P Steinbach; Johannes Rieger
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

6.  The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation.

Authors:  Jana Portnow; Behnam Badie; Mike Chen; An Liu; Suzette Blanchard; Timothy W Synold
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

Review 7.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

8.  Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized 13 C-MRI.

Authors:  Tatsuya Kawai; Jeffrey R Brender; Jennifer A Lee; Tamalee Kramp; Shun Kishimoto; Murali C Krishna; Philip Tofilon; Kevin A Camphausen
Journal:  NMR Biomed       Date:  2021-05-03       Impact factor: 4.478

Review 9.  Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer.

Authors:  Violet Y Tu; Asma Ayari; Roddy S O'Connor
Journal:  Antibodies (Basel)       Date:  2021-06-28

10.  Advances in gas chromatographic methods for the identification of biomarkers in cancer.

Authors:  Konstantinos A Kouremenos; Mikael Johansson; Philip J Marriott
Journal:  J Cancer       Date:  2012-09-26       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.